A Role for Curative Surgery in the Treatment of Selected Patients with Metastatic Breast Cancer

Author:

Singletary S. Eva1,Walsh Garrett2,Vauthey Jean-Nicolas1,Curley Steven1,Sawaya Raymond3,Weber Kristin L.1,Meric Funda1,Hortobágyi Gabriel N.4

Affiliation:

1. Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

2. Department of Thoracic and Cardiovascular Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

3. Department of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

4. Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

Abstract

Abstract Learning Objectives After completing this course, the reader will be able to: Explain how surgery in combination with systemic therapy may offer significantly improved survival outcomes in selected patients with metastatic breast cancer. Appreciate the value of chest x-rays in follow-up to identify patients with pulmonary or sternal metastases who may be candidates for surgical resection. Recognize that the concept of a “cure” in breast cancer is evolving to mean a prolonged period of survival without significant symptoms. Access and take the CME test online and receive one hour of AMA PRA category 1 credit at CME.TheOncologist.com Although metastatic breast cancer is widely believed to carry a grim prognosis, treatment developments over the past 25 years have greatly improved survival outcomes in these patients. In selected cases, aggressive treatment approaches may occasionally result in long-term survival of 15 years or more. This review considers the role of surgery in the treatment of single or multiple metastatic lesions restricted to one site. For each site, available literature from 1992–2002 was assessed to determine the role of surgery on survival outcomes and to determine appropriate criteria for selecting the best candidates for surgery. For lung, liver, brain, and sternum metastases, the use of surgery with or without adjuvant therapy resulted in greater median survival times and 5-year survival rates. The best candidate for surgery had no evidence of additional metastatic disease, good performance status, and a long disease-free interval after treatment of the primary tumor. Current treatment standards for breast cancer follow-up do not include imaging studies other than mammography. The addition of chest x-rays as part of routine follow-up should be considered as a cost-effective approach for early assessment of metastases to the lung or sternum that may be appropriate for surgical excision.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Reference68 articles.

1. Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer;Greenberg;J Clin Oncol,1996

2. Improvement in breast cancer survival: results from M.D. Anderson Cancer Center protocols from 1975–2000;Giordano;Proc Am Soc Clin Oncol,2002

3. Recent advances in the treatment of metastatic breast cancer;O'Shaughnessy;Update Clin Oncol,2002

4. Combined-modality approach for patients with isolated recurrences of breast cancer (IV-NED): the M.D. Anderson experience;Holmes;Breast Disease,1993

5. Fluorouracil, doxorubicin, and cyclophosphamide followed by tamoxifen as adjuvant treatment for patients with stage IV breast cancer with no evidence of disease;Rivera;Breast J,2002

Cited by 140 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Operative Management in Stage IV Breast Cancer;Surgical Clinics of North America;2023-02

2. Breast cancer liver metastasis: Pathogenesis and clinical implications;Frontiers in Oncology;2022-10-25

3. Cáncer de mama metastásico;EMC - Ginecología-Obstetricia;2022-07

4. Utility of liver resection for breast cancer liver metastases, time for action;Hepatobiliary Surgery and Nutrition;2022-06

5. Breast cancer liver metastases: systematic review and time to event meta-analysis with comparison between available treatments;The Annals of The Royal College of Surgeons of England;2022-02-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3